Bio­phar­ma's 20 high­est-paid CEOs of 2022, each bring­ing in $20M+ pay­days

Even in a down year for much of the bio­phar­ma mar­ket, 20 CEOs brought in pay pack­ages val­ued at more than $20 mil­lion, an End­points News analy­sis found.

End­points col­lect­ed da­ta on more than 350 CEO com­pen­sa­tion pack­ages, cov­er­ing a wide range of phar­ma, biotech, and life sci­ences com­pa­nies. All told, the 20 largest earn­ers made over $725 mil­lion in 2022 — an av­er­age pack­age of $36.4 mil­lion. Three brought in pay­days over $50 mil­lion, and one CEO broke the $100 mil­lion mark.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER